Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Código QR

Indication-specific tumor evolution and its impact on neoantigen targeting and biomarkers for individualized cancer immunotherapies

Guardado en:

Detalles Bibliográficos
Autores principales:	Andrew Wallace, Ryan Jones, Richard Bourgon, Guang-Yu Yang, Amy A Lo, Daniel Oreper, Nicolas Lounsbury, Charles Havnar, Ximo Pechuan-Jorge, Thomas D Wu, Katrina Krogh, Oliver A Zill
Formato:	article
Lenguaje:	EN
Publicado:	BMJ Publishing Group 2021
Materias:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/ae3220fd2a674ad6a63ade71ac6c61d6
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Intertwining DNA-RNA nanocapsules loaded with tumor neoantigens as synergistic nanovaccines for cancer immunotherapy
por: Guizhi Zhu, et al.
Publicado: (2017)

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors
por: Samuel Rivero-Hinojosa, et al.
Publicado: (2021)

Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
por: M. Fehlings, et al.
Publicado: (2017)

Author Correction: Checkpoint blockade immunotherapy reshapes the high-dimensional phenotypic heterogeneity of murine intratumoural neoantigen-specific CD8+ T cells
por: M. Fehlings, et al.
Publicado: (2018)

Neoantigens elicit T cell responses in breast cancer
por: Takafumi Morisaki, et al.
Publicado: (2021)

Protein citrullination as a source of cancer neoantigens
por: Makoto Kobayashi, et al.
Publicado: (2021)

Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy
por: Yang-Hong Dai, et al.
Publicado: (2021)

Novel emerging biomarkers to immunotherapy in kidney cancer
por: Yasser Ged, et al.
Publicado: (2021)

Cancer neoantigen prioritization through sensitive and reliable proteogenomics analysis
por: Bo Wen, et al.
Publicado: (2020)

Structural engineering of chimeric antigen receptors targeting HLA-restricted neoantigens
por: Michael S. Hwang, et al.
Publicado: (2021)

Mathematical model of a personalized neoantigen cancer vaccine and the human immune system.
por: Marisabel Rodriguez Messan, et al.
Publicado: (2021)

Multi-step screening of neoantigens’ HLA- and TCR-interfaces improves prediction of survival
por: Guilhem Richard, et al.
Publicado: (2021)

Advances in Biomarkers for Immunotherapy of Non-small Cell Lung Cancer
por: Chuan HUANG, et al.
Publicado: (2021)

An engineered oncolytic virus expressing PD-L1 inhibitors activates tumor neoantigen-specific T cell responses
por: Guan Wang, et al.
Publicado: (2020)

Integrative multi-omics analysis of muscle-invasive bladder cancer identifies prognostic biomarkers for frontline chemotherapy and immunotherapy
por: Qianxing Mo, et al.
Publicado: (2020)

Old <named-content content-type="genus-species">Cryptococcus neoformans</named-content> Cells Contribute to Virulence in Chronic Cryptococcosis
por: Tejas Bouklas, et al.
Publicado: (2013)

Structural basis for oligoclonal T cell recognition of a shared p53 cancer neoantigen
por: Daichao Wu, et al.
Publicado: (2020)

Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Martin Lauss, et al.
Publicado: (2017)

Functional analysis of peripheral and intratumoral neoantigen-specific TCRs identified in a patient with melanoma
por: Melanie Boxberg, et al.
Publicado: (2021)

Individualized Proteogenomics Reveals the Mutational Landscape of Melanoma Patients in Response to Immunotherapy
por: Marisa Schmitt, et al.
Publicado: (2021)

Adenoviral vaccine targeting multiple neoantigens as strategy to eradicate large tumors combined with checkpoint blockade
por: Anna Morena D’Alise, et al.
Publicado: (2019)

The viral expression and immune status in human cancers and insights into novel biomarkers of immunotherapy
por: Siyuan Chen, et al.
Publicado: (2021)

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study
por: Lang D, et al.
Publicado: (2020)

Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers
por: Daniel J. McGrail, et al.
Publicado: (2018)

Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Martin Lauss, et al.
Publicado: (2020)

Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resection
por: Daniel Delitto, et al.
Publicado: (2021)

VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes
por: Andreia Gameiro, et al.
Publicado: (2021)

Nutritional Status as a Predictive Biomarker for Immunotherapy Outcomes in Advanced Head and Neck Cancer
por: Meytal Guller, et al.
Publicado: (2021)

Increased expression of peptides from non-coding genes in cancer proteomics datasets suggests potential tumor neoantigens
por: Rong Xiang, et al.
Publicado: (2021)

FDG PET biomarkers for prediction of survival in metastatic melanoma prior to anti-PD1 immunotherapy
por: A. Flaus, et al.
Publicado: (2021)

Improving Immunotherapy Efficacy in Soft-Tissue Sarcomas: A Biomarker Driven and Histotype Tailored Review
por: Matthieu Roulleaux Dugage, et al.
Publicado: (2021)

Nine Pyroptosis-Related lncRNAs are Identified as Biomarkers for Predicting the Prognosis and Immunotherapy of Endometrial Carcinoma
por: Liang D, et al.
Publicado: (2021)

Programmed Cell Death Protein Ligand 2 Is a Potential Biomarker That Predicts the Efficacy of Immunotherapy
por: Aoyun Wang, et al.
Publicado: (2021)

Cost-effectiveness of treatment optimisation with biomarkers for immunotherapy in solid tumours: a systematic review protocol
por: Valentina Lorenzoni, et al.
Publicado: (2021)

An HLA-A*11:01-Binding Neoantigen from Mutated NPM1 as Target for TCR Gene Therapy in AML
por: Dyantha I. van der Lee, et al.
Publicado: (2021)

Pan-Cancer Analysis of IGF-1 and IGF-1R as Potential Prognostic Biomarkers and Immunotherapy Targets
por: Yinqi Zhang, et al.
Publicado: (2021)

Heterogeneity of tumor-infiltrating lymphocytes ascribed to local immune status rather than neoantigens by multi-omics analysis of glioblastoma multiforme
por: Lin Feng, et al.
Publicado: (2017)

Correction: Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Publicado: (2021)

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Amy J. Petty, et al.
Publicado: (2021)

Omentin: a biomarker of cardiovascular risk in individuals with axial spondyloarthritis
por: Fernanda Genre, et al.
Publicado: (2020)